Osprey Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Osprey Private Wealth's REGN Position: Q3 2026 in Review
Osprey Private Wealth increased its Regeneron Pharmaceuticals (REGN) stake by 7.9% in Q3 2026, buying an estimated $546K and bringing the position to 9,890 shares worth $7.5M. The position accounts for 1.81% of the portfolio, ranked #20.
Osprey Private Wealth first reported a position in REGN in Q1 2025 and has held it in 7 quarters since. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Osprey Private Wealth held 9,890 shares of Regeneron Pharmaceuticals worth $7.5M as of Q3 2026.
- Osprey Private Wealth bought 723 Regeneron Pharmaceuticals shares in Q3 2026, an estimated $546K.
- Regeneron Pharmaceuticals made up 1.81% of Osprey Private Wealth's portfolio in Q3 2026, its #20 holding.
- Osprey Private Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Osprey Private Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.